We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Fine Mesh System Treats Intracranial Aneurysms

By HospiMedica International staff writers
Posted on 04 Mar 2020
Print article
Image: The Contour Neurovascular System (Photo courtesy of Cerus Endovascular)
Image: The Contour Neurovascular System (Photo courtesy of Cerus Endovascular)
A unique intrasaccular implant deployed across the neck of an aneurysm sac provides a combination of flow diversion and flow disruption through a single device.

The Cerus Endovascular (Oxford, United Kingdom) Contour Neurovascular System is a pre-shaped structure of fine mesh braid with shape memory properties delivered to the aneurysm via an endovascular micro-catheter. The system, which is designed to be self-anchored for stability and re-sheathable for precise placement, targets the neck of the aneurysm, away from the vulnerable dome, which also makes sizing criteria less restrictive. Contour can thus be used to treat a range of aneurysm morphologies, including unruptured wide-necked bifurcation and bifurcation aneurysms.

Benefits of the system include a combination of flow diversion at the neck of the aneurysm and flow disruption within the aneurysm sac; support of neo-intimal growth across the mesh at the aneurysm neck and subsequent thrombosis; deployment with existing clinical techniques; an electrolytic method of detachment; no intra-arterial stabilizing component; a reduction or even elimination of the need for dual anti-platelet therapy; and straightforward sizing, as Contour does not aim for bulk replacement of the aneurysmal cavity, but only targets the neck area.

“The Contour Neurovascular System delivers an important clinical option and represents a new, and potentially disruptive, standalone solution for the treatment of bifurcated saccular intracranial aneurysms,” said Stephen Griffin, MD, President of Cerus Endovascular. “Physicians who have used the System have highlighted the benefits inherent in its unique simplicity, including a simple sizing approach of the device to the aneurysm width, ease of deliverability, and controlled deployment.”

“The Contour System combines the benefits of flow disruption and redefinition of the aneurysm-to-parent vessel- border without any material in the parent artery; thus, it doesn´t mandate long-term antiplatelet therapy. Angulation and irregularity of the aneurysm dome seemed to play a lesser role, as well,” said Professor Thomas Liebig, MD, of Ludwig Maximillian University Hospital (Munich, Germany). “We are aware of the need for a more valid database with more cases to support these impressions, but at the moment we are quite content with our initial experience and look forward to the Co-investigators experiences and to the first control visit of the patients we have treated so far.”

Related Links:
Cerus Endovascular

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.